应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NPCE NeuroPace Inc.
休市中 01-23 16:00:00 EST
16.71
-0.33
-1.94%
盘后
16.71
+0.00
0.00%
18:29 EST
最高
17.07
最低
16.67
成交量
9.38万
今开
16.98
昨收
17.04
日振幅
2.38%
总市值
5.53亿
流通市值
3.76亿
总股本
3,308万
成交额
157.82万
换手率
0.42%
流通股本
2,252万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Neuropace, Inc.盘中异动 股价大涨5.30%报16.70美元
市场透视 · 01-06
Neuropace, Inc.盘中异动 股价大涨5.30%报16.70美元
Neuropace向FDA提交PMA补充申请,寻求扩大RNS®系统在特发性全身性癫痫的适应症
美股速递 · 2025-12-17
Neuropace向FDA提交PMA补充申请,寻求扩大RNS®系统在特发性全身性癫痫的适应症
NeuroPace: 计划在年末前向FDA提交Nautilus PMA补充申请以扩大IGE适应症
美股速递 · 2025-12-08
NeuroPace: 计划在年末前向FDA提交Nautilus PMA补充申请以扩大IGE适应症
Neuropace, Inc.盘中异动 股价大涨5.12%
市场透视 · 2025-11-24
Neuropace, Inc.盘中异动 股价大涨5.12%
NeuroPace Inc. - 初次植入手术支付率提高约43%(+530美元),更换手术提高45%(+260美元)
美股速递 · 2025-11-24
NeuroPace Inc. - 初次植入手术支付率提高约43%(+530美元),更换手术提高45%(+260美元)
Neuropace, Inc.盘中异动 股价大跌5.23%
市场透视 · 2025-11-04
Neuropace, Inc.盘中异动 股价大跌5.23%
Neuropace, Inc.盘中异动 股价大涨5.03%报10.44美元
市场透视 · 2025-09-23
Neuropace, Inc.盘中异动 股价大涨5.03%报10.44美元
神经系统医疗设备公司NeuroPace(NPCE)股价下跌5.2%。该公司昨日将2025年营收指引上调至9400-980
智通财经 · 2025-08-14
神经系统医疗设备公司NeuroPace(NPCE)股价下跌5.2%。该公司昨日将2025年营收指引上调至9400-980
专注于神经系统疾病治疗创新方案的医疗设备公司NeuroPace(NPCE)将2025年营收指引上调至9400-9800万
智通财经 · 2025-08-13
专注于神经系统疾病治疗创新方案的医疗设备公司NeuroPace(NPCE)将2025年营收指引上调至9400-9800万
NeuroPace 2025财年Q2业绩会总结及问答精华:RNS系统销售强劲推动增长
业绩会速递 · 2025-08-13
NeuroPace 2025财年Q2业绩会总结及问答精华:RNS系统销售强劲推动增长
Neuropace, Inc.盘中异动 股价大跌5.21%
市场透视 · 2025-08-06
Neuropace, Inc.盘中异动 股价大跌5.21%
Neuropace, Inc.盘中异动 早盘股价大跌5.09%报10.44美元
市场透视 · 2025-03-10
Neuropace, Inc.盘中异动 早盘股价大跌5.09%报10.44美元
Neuropace, Inc.2024财年实现净利润-27.14百万美元,同比增加17.66%
市场透视 · 2025-03-10
Neuropace, Inc.2024财年实现净利润-27.14百万美元,同比增加17.66%
Neuropace, Inc.盘中异动 早盘大幅下挫5.93%
市场透视 · 2025-03-06
Neuropace, Inc.盘中异动 早盘大幅下挫5.93%
NeuroPace(NPCE.US):2024年Q4财报实现营收2146.6万美元,前值为1801.2万美元,预期值为2114万美元;每股收益为-0.18美元,前值为-0.23美元,预期值为-0.22美元。
金融界 · 2025-03-05
NeuroPace(NPCE.US):2024年Q4财报实现营收2146.6万美元,前值为1801.2万美元,预期值为2114万美元;每股收益为-0.18美元,前值为-0.23美元,预期值为-0.22美元。
NeuroPace Q4每股收益$(0.18) 优于预期$(0.22),销售额$21.47M 超预期$21.17M
财报速递 · 2025-03-05
NeuroPace Q4每股收益$(0.18) 优于预期$(0.22),销售额$21.47M 超预期$21.17M
Neuropace, Inc.盘中异动 早盘急速跳水5.59%
市场透视 · 2025-03-04
Neuropace, Inc.盘中异动 早盘急速跳水5.59%
Neuropace, Inc.盘中异动 早盘大幅下挫7.03%
市场透视 · 2025-03-03
Neuropace, Inc.盘中异动 早盘大幅下挫7.03%
Neuropace, Inc.盘中异动 股价大跌5.04%
市场透视 · 2025-02-28
Neuropace, Inc.盘中异动 股价大跌5.04%
Neuropace, Inc.盘中异动 早盘急速下跌5.24%
市场透视 · 2025-02-21
Neuropace, Inc.盘中异动 早盘急速下跌5.24%
加载更多
公司概况
公司名称:
NeuroPace Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
NeuroPace, Inc.于1997年11月19日在特拉华州成立。该公司是一家医疗器械公司,专注于通过减少或消除使人衰弱的癫痫发作的发生来改变癫痫患者的生活。
发行价格:
--
{"stockData":{"symbol":"NPCE","market":"US","secType":"STK","nameCN":"NeuroPace Inc.","latestPrice":16.71,"timestamp":1769202000000,"preClose":17.04,"halted":0,"volume":93755,"hourTrading":{"tag":"盘后","latestPrice":16.71,"preClose":16.71,"latestTime":"18:29 EST","volume":758,"amount":12666.18,"timestamp":1769210941978,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.019366197183098493,"floatShares":22522505,"shares":33081498,"eps":-0.753018,"marketStatus":"休市中","change":-0.33,"latestTime":"01-23 16:00:00 EST","open":16.98,"high":17.07,"low":16.665,"amount":1578217.1045900001,"amplitude":0.023768,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.753018,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1769418000000},"marketStatusCode":7,"adr":0,"listingDate":1619064000000,"exchange":"NASDAQ","adjPreClose":17.04,"preHourTrading":{"tag":"盘前","latestPrice":17.12,"preClose":17.04,"latestTime":"08:29 EST","volume":27,"amount":462.24,"timestamp":1769174989599,"change":0.08,"changeRate":0.004695,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":16.71,"preClose":16.71,"latestTime":"18:29 EST","volume":758,"amount":12666.18,"timestamp":1769210941978,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5490432840901963,"impliedVol":0.2176,"impliedVolPercentile":0.0558},"requestUrl":"/m/hq/s/NPCE","defaultTab":"news","newsList":[{"id":"2601164048","title":"Neuropace, Inc.盘中异动 股价大涨5.30%报16.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601164048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601164048?lang=zh_cn&edition=full","pubTime":"2026-01-06 22:56","pubTimestamp":1767711375,"startTime":"0","endTime":"0","summary":"北京时间2026年01月06日22时56分,Neuropace, Inc.股票出现异动,股价快速上涨5.30%。截至发稿,该股报16.70美元/股,成交量2.8144万股,换手率0.08%,振幅5.20%。Neuropace, Inc.股票所在的医疗器械行业中,整体涨幅为1.88%。Neuropace, Inc.公司简介:NeuroPace Inc 是一家处于商业化阶段的医疗设备公司,专注于通过减少或消除使人衰弱的癫痫发作来改变癫痫患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106225615a4a3e77a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106225615a4a3e77a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NPCE","BK4082","BK4539"],"gpt_icon":0},{"id":"1162836091","title":"Neuropace向FDA提交PMA补充申请,寻求扩大RNS®系统在特发性全身性癫痫的适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=1162836091","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162836091?lang=zh_cn&edition=full","pubTime":"2025-12-17 21:01","pubTimestamp":1765976474,"startTime":"0","endTime":"0","summary":"Neuropace向FDA提交PMA补充申请,寻求扩大RNS®系统在特发性全身性癫痫的适应症。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4539","NPCE"],"gpt_icon":0},{"id":"1125787521","title":"NeuroPace: 计划在年末前向FDA提交Nautilus PMA补充申请以扩大IGE适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=1125787521","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125787521?lang=zh_cn&edition=full","pubTime":"2025-12-08 21:08","pubTimestamp":1765199336,"startTime":"0","endTime":"0","summary":"NeuroPace: 计划在年末前向FDA提交Nautilus PMA补充申请以扩大IGE适应症","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NPCE","BK4539","BK4082"],"gpt_icon":0},{"id":"2586455446","title":"Neuropace, Inc.盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586455446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586455446?lang=zh_cn&edition=full","pubTime":"2025-11-24 23:06","pubTimestamp":1763996775,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日23时06分,Neuropace, Inc.股票出现异动,股价快速上涨5.12%。截至发稿,该股报15.09美元/股,成交量3.9955万股,换手率0.12%,振幅4.25%。Neuropace, Inc.股票所在的医疗器械行业中,整体涨幅为0.46%。Neuropace, Inc.公司简介:NeuroPace Inc 是一家处于商业化阶段的医疗设备公司,专注于通过减少或消除使人衰弱的癫痫发作来改变癫痫患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511242306159517b24a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511242306159517b24a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NPCE","BK4082","BK4539"],"gpt_icon":0},{"id":"1147878682","title":"NeuroPace Inc. - 初次植入手术支付率提高约43%(+530美元),更换手术提高45%(+260美元)","url":"https://stock-news.laohu8.com/highlight/detail?id=1147878682","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147878682?lang=zh_cn&edition=full","pubTime":"2025-11-24 21:03","pubTimestamp":1763989391,"startTime":"0","endTime":"0","summary":"NeuroPace Inc. - 初次植入手术支付率提高约43%(+530美元),更换手术提高45%(+260美元)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","NPCE","BK4082"],"gpt_icon":0},{"id":"2580275842","title":"Neuropace, Inc.盘中异动 股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580275842","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580275842?lang=zh_cn&edition=full","pubTime":"2025-11-04 01:45","pubTimestamp":1762191916,"startTime":"0","endTime":"0","summary":"北京时间2025年11月04日01时45分,Neuropace, Inc.股票出现波动,股价大幅跳水5.23%。Neuropace, Inc.股票所在的医疗器械行业中,整体跌幅为0.50%。其相关个股中,Spectral Ai Inc C/Wts 、Cvrx, Inc.、Picard Medical, Inc.涨幅较大,Invo Fertility, Inc.、Profusa, Inc.、Clearpoint Neuro Inc.较为活跃,换手率分别为52.72%、14.58%、11.41%,振幅较大的相关个股有Profusa, Inc.、Picard Medical, Inc.、Butterfly Network, Inc.,振幅分别为47.70%、25.82%、19.18%。Neuropace, Inc.公司简介:NeuroPace Inc 是一家处于商业化阶段的医疗设备公司,专注于通过减少或消除使人衰弱的癫痫发作来改变癫痫患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104014516a485aef6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104014516a485aef6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4539","NPCE"],"gpt_icon":0},{"id":"2569717771","title":"Neuropace, Inc.盘中异动 股价大涨5.03%报10.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2569717771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569717771?lang=zh_cn&edition=full","pubTime":"2025-09-23 03:45","pubTimestamp":1758570349,"startTime":"0","endTime":"0","summary":"北京时间2025年09月23日03时45分,Neuropace, Inc.股票出现波动,股价急速拉升5.03%。截至发稿,该股报10.44美元/股,成交量15.1217万股,换手率0.46%,振幅5.23%。Neuropace, Inc.股票所在的医疗器械行业中,整体涨幅为0.55%。Neuropace, Inc.公司简介:NeuroPace Inc 是一家处于商业化阶段的医疗设备公司,专注于通过减少或消除使人衰弱的癫痫发作来改变癫痫患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923034550a43cfe93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923034550a43cfe93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4082","NPCE"],"gpt_icon":0},{"id":"2559610963","title":"神经系统医疗设备公司NeuroPace(NPCE)股价下跌5.2%。该公司昨日将2025年营收指引上调至9400-980","url":"https://stock-news.laohu8.com/highlight/detail?id=2559610963","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559610963?lang=zh_cn&edition=full","pubTime":"2025-08-14 23:13","pubTimestamp":1755184418,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4539","NPCE","BK4082","159873"],"gpt_icon":0},{"id":"2559600052","title":"专注于神经系统疾病治疗创新方案的医疗设备公司NeuroPace(NPCE)将2025年营收指引上调至9400-9800万","url":"https://stock-news.laohu8.com/highlight/detail?id=2559600052","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559600052?lang=zh_cn&edition=full","pubTime":"2025-08-13 22:34","pubTimestamp":1755095660,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["159873","BK4539","162717","BK4082","NPCE"],"gpt_icon":0},{"id":"1122608130","title":"NeuroPace 2025财年Q2业绩会总结及问答精华:RNS系统销售强劲推动增长","url":"https://stock-news.laohu8.com/highlight/detail?id=1122608130","media":"业绩会速递","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122608130?lang=zh_cn&edition=full","pubTime":"2025-08-13 06:02","pubTimestamp":1755036139,"startTime":"0","endTime":"0","summary":"NeuroPace管理层强调,2025财年第二季度的强劲表现主要得益于核心RNS系统销售的增长、毛利率的提升以及成功的债务再融资。NeuroPace计划在2025年提交PMA补充申请,并继续推进其首个AI驱动的工作流程工具的开发和监管发布。NeuroPace报告2025财年第二季度收入为2350万美元,同比增长22%。Project CARE和RNS系统的扩展对市场产生了积极影响,Nautilus试验的数据也显示出显著的临床意义。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NPCE"],"gpt_icon":0},{"id":"2557313957","title":"Neuropace, Inc.盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557313957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557313957?lang=zh_cn&edition=full","pubTime":"2025-08-06 00:18","pubTimestamp":1754410695,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日00时18分,Neuropace, Inc.股票出现波动,股价快速下跌5.21%。Neuropace, Inc.股票所在的医疗器械行业中,整体跌幅为0.29%。其相关个股中,Heartsciences Inc C/Wts 、Tactile Systems Technology, Inc.、Dih Holdings Us Inc C/Wts 20/04/2028 涨幅较大,Invo Fertility, Inc.、Tenon Medical, Inc.、Heartsciences Inc.较为活跃,换手率分别为256.37%、32.15%、20.89%,振幅较大的相关个股有Heartsciences Inc C/Wts 、Ainos Inc C/Wts 29/07/2027 、Tactile Systems Technology, Inc.,振幅分别为40.59%、32.50%、28.36%。Neuropace, Inc.公司简介:NeuroPace Inc 是一家处于商业化阶段的医疗设备公司,专注于通过减少或消除使人衰弱的癫痫发作来改变癫痫患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508060018169735a687&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508060018169735a687&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4082","NPCE"],"gpt_icon":0},{"id":"2518627137","title":"Neuropace, Inc.盘中异动 早盘股价大跌5.09%报10.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518627137","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518627137?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:59","pubTimestamp":1741615186,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时59分,Neuropace, Inc.股票出现波动,股价快速跳水5.09%。截至发稿,该股报10.44美元/股,成交量1.1727万股,换手率0.04%,振幅4.14%。Neuropace, Inc.股票所在的医疗器械行业中,整体跌幅为1.09%。Neuropace, Inc.公司简介:NeuroPace Inc 是一家处于商业阶段的医疗设备公司,致力于通过减少或消除使人衰弱的癫痫发作来改变癫痫患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215946abf30743&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215946abf30743&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4539","NPCE"],"gpt_icon":0},{"id":"2518281019","title":"Neuropace, Inc.2024财年实现净利润-27.14百万美元,同比增加17.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518281019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518281019?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:00","pubTimestamp":1741536022,"startTime":"0","endTime":"0","summary":"3月10日,Neuropace, Inc.公布财报,公告显示公司2024财年净利润为-27.14百万美元,同比增加17.66%;其中营业收入为79.91百万美元,同比增加22.15%,每股基本收益为-0.93美元。从资产负债表来看,Neuropace, Inc.总负债86.63百万美元,其中短期债务1.86百万美元,资产负债比为1.10,流动比率为5.37。机构评级:截至2025年3月10日,当前有7家机构对Neuropace, Inc.目标价做出预测,其中目标均价为17.57美元,其中最低目标价为14.00美元,最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000032abf174ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000032abf174ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NPCE"],"gpt_icon":0},{"id":"2517166094","title":"Neuropace, Inc.盘中异动 早盘大幅下挫5.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517166094","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517166094?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:42","pubTimestamp":1741272129,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时42分,Neuropace, Inc.股票出现波动,股价急速下挫5.93%。Neuropace, Inc.股票所在的医疗器械行业中,整体跌幅为1.67%。其相关个股中,古特拉、Xylo Technologies Ltd、Co-Diagnostics, Inc.涨幅较大,古特拉、Tivic Health Systems, Inc.、Reshape Lifesciences, Inc.较为活跃,换手率分别为150.34%、2.68%、1.91%,振幅较大的相关个股有古特拉、拜尔德医疗、Ainos, Inc.,振幅分别为13.25%、13.23%、12.66%。Neuropace, Inc.公司简介:NeuroPace Inc 是一家处于商业阶段的医疗设备公司,致力于通过减少或消除使人衰弱的癫痫发作来改变癫痫患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224209989eb6d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224209989eb6d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NPCE","BK4539","BK4082"],"gpt_icon":0},{"id":"2517817799","title":"NeuroPace(NPCE.US):2024年Q4财报实现营收2146.6万美元,前值为1801.2万美元,预期值为2114万美元;每股收益为-0.18美元,前值为-0.23美元,预期值为-0.22美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517817799","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517817799?lang=zh_cn&edition=full","pubTime":"2025-03-05 05:29","pubTimestamp":1741123795,"startTime":"0","endTime":"0","summary":"NeuroPace(NPCE.US):2024年Q4财报实现营收2146.6万美元,前值为1801.2万美元,预期值为2114万美元;每股收益为-0.18美元,前值为-0.23美元,预期值为-0.22美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05052948524500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NPCE"],"gpt_icon":0},{"id":"1148434711","title":"NeuroPace Q4每股收益$(0.18) 优于预期$(0.22),销售额$21.47M 超预期$21.17M","url":"https://stock-news.laohu8.com/highlight/detail?id=1148434711","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148434711?lang=zh_cn&edition=full","pubTime":"2025-03-05 05:16","pubTimestamp":1741122997,"startTime":"0","endTime":"0","summary":"NeuroPace 报告季度每股亏损$,优于分析师共识预期的$,提高了18.18%。这相比去年同期每股亏损$ 增加了21.74%。公司报告季度销售额为$21.47百万,超出分析师共识预期的$21.17百万1.39%。以上内容来自Benzinga Earnings专栏,原文如下:NeuroPace reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 18.18 percent. This is a 21.74 percent increase over losses of $ per share from the same period last year. The company reported quarterly sales of $21.47 million which beat the analyst consensus estimate of $21.17 million by 1.39 percent. This is a 19.18 p","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"NeuroPace Q4每股收益$(0.18) 优于预期$(0.22),销售额$21.47M 超预期$21.17M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NPCE"],"gpt_icon":0},{"id":"2516677918","title":"Neuropace, Inc.盘中异动 早盘急速跳水5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677918","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677918?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:35","pubTimestamp":1741098916,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时35分,Neuropace, Inc.股票出现异动,股价大幅跳水5.59%。Neuropace, Inc.股票所在的医疗器械行业中,整体跌幅为0.25%。其相关个股中,908 Devices Inc.、Pavmed Inc C/Wts 30/04/2025 Class Z、Envoy Medical Inc C/Wts 29/09/2028 涨幅较大,908 Devices Inc.、Reshape Lifesciences, Inc.、Aethlon Medical, Inc.较为活跃,换手率分别为59.43%、5.13%、1.65%,振幅较大的相关个股有908 Devices Inc.、Senseonics Holdings, Inc.、Ainos, Inc.,振幅分别为12.63%、9.20%、9.01%。Neuropace, Inc.公司简介:NeuroPace Inc 是一家处于商业阶段的医疗设备公司,致力于通过减少或消除使人衰弱的癫痫发作来改变癫痫患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223516abe7f0ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223516abe7f0ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NPCE","BK4539","BK4082"],"gpt_icon":0},{"id":"2516375536","title":"Neuropace, Inc.盘中异动 早盘大幅下挫7.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516375536","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516375536?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:00","pubTimestamp":1741014032,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时00分,Neuropace, Inc.股票出现异动,股价急速下跌7.03%。Neuropace, Inc.股票所在的医疗器械行业中,整体涨幅为0.87%。其相关个股中,Pavmed Inc C/Wts 30/04/2025 Class Z、飞天兆业、古特拉涨幅较大,Tivic Health Systems, Inc.、Reshape Lifesciences, Inc.、Sintx Technologies, Inc.较为活跃,换手率分别为6.46%、4.85%、4.30%,振幅较大的相关个股有Venus Concept Inc.、Envoy Medical, Inc.、Pulmonx Corporation,振幅分别为15.78%、14.60%、14.50%。Neuropace, Inc.公司简介:NeuroPace Inc 是一家处于商业阶段的医疗设备公司,致力于通过减少或消除使人衰弱的癫痫发作来改变癫痫患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230032989a180a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230032989a180a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NPCE","BK4082","BK4539"],"gpt_icon":0},{"id":"2514334858","title":"Neuropace, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514334858","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514334858?lang=zh_cn&edition=full","pubTime":"2025-02-28 03:30","pubTimestamp":1740684631,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时30分,Neuropace, Inc.股票出现波动,股价大幅下挫5.04%。Neuropace, Inc.股票所在的医疗器械行业中,整体跌幅为0.18%。Neuropace, Inc.公司简介:NeuroPace Inc 是一家处于商业阶段的医疗设备公司,致力于通过减少或消除使人衰弱的癫痫发作来改变癫痫患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228033032a256bd0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228033032a256bd0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NPCE","BK4082","BK4539"],"gpt_icon":0},{"id":"2513296611","title":"Neuropace, Inc.盘中异动 早盘急速下跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513296611?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:37","pubTimestamp":1740148677,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时37分,Neuropace, Inc.股票出现波动,股价急速下跌5.24%。Neuropace, Inc.股票所在的医疗器械行业中,整体跌幅为0.56%。其相关个股中,Pavmed Inc C/Wts 30/04/2025 Class Z、Sintx Technologies, Inc.、Accelerate Diagnostics, Inc.涨幅较大,Sintx Technologies, Inc.、沃氪医疗、Reshape Lifesciences, Inc.较为活跃,换手率分别为22.69%、10.90%、9.51%,振幅较大的相关个股有Sintx Technologies, Inc.、沃氪医疗、Heartsciences Inc.,振幅分别为15.00%、13.43%、9.97%。Neuropace, Inc.公司简介:NeuroPace Inc 是一家处于商业阶段的医疗设备公司,致力于通过减少或消除使人衰弱的癫痫发作来改变癫痫患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223758962b7ce7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223758962b7ce7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4539","NPCE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neuropace.com","stockEarnings":[{"period":"1week","weight":-0.0136},{"period":"1month","weight":0.0321},{"period":"3month","weight":0.5945},{"period":"6month","weight":0.8608},{"period":"1year","weight":0.1919},{"period":"ytd","weight":0.0823}],"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":-0.0017},{"period":"3month","weight":0.0177},{"period":"6month","weight":0.0818},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.0107}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NeuroPace, Inc.于1997年11月19日在特拉华州成立。该公司是一家医疗器械公司,专注于通过减少或消除使人衰弱的癫痫发作的发生来改变癫痫患者的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.534101},{"month":2,"riseRate":0.5,"avgChangeRate":0.027762},{"month":3,"riseRate":0.25,"avgChangeRate":-0.069398},{"month":4,"riseRate":0.25,"avgChangeRate":-0.001962},{"month":5,"riseRate":0.2,"avgChangeRate":-0.144641},{"month":6,"riseRate":0.6,"avgChangeRate":-0.044447},{"month":7,"riseRate":0.4,"avgChangeRate":-0.04203},{"month":8,"riseRate":0.6,"avgChangeRate":0.216975},{"month":9,"riseRate":0.4,"avgChangeRate":-0.065676},{"month":10,"riseRate":0,"avgChangeRate":-0.132059},{"month":11,"riseRate":0.6,"avgChangeRate":0.163487},{"month":12,"riseRate":0.6,"avgChangeRate":0.015944}],"exchange":"NASDAQ","name":"NeuroPace Inc.","nameEN":"NeuroPace Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NeuroPace Inc.(NPCE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NeuroPace Inc.(NPCE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NeuroPace Inc.,NPCE,NeuroPace Inc.股票,NeuroPace Inc.股票老虎,NeuroPace Inc.股票老虎国际,NeuroPace Inc.行情,NeuroPace Inc.股票行情,NeuroPace Inc.股价,NeuroPace Inc.股市,NeuroPace Inc.股票价格,NeuroPace Inc.股票交易,NeuroPace Inc.股票购买,NeuroPace Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NeuroPace Inc.(NPCE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NeuroPace Inc.(NPCE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}